A Study of IBR854 Combined With Pazopanib Versus Pazopanib in Advanced Renal Cell Carcinoma

Clinical trial NCT07087158 · RECRUITING

Trial details

NCT number: NCT07087158
Sponsor: Imbioray (Hangzhou) Biomedicine Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma (RCC)

Start date: 2025-09-08
Primary completion: 2026-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.